In anticipation of FDA emergency use authorization, Duke is preparing to participate in an efficient and equitable distribution of the vaccine in close coordination with NC DHHS and local health departments.

The vaccine will be offered in a CDC-defined phased approach that prioritizes healthcare workers who are most likely to be exposed to the COVID-19 virus while providing care to patients – including staff within Duke’s clinical and research laboratories.

For details, view the full message posted on Duke Today.